Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?

Francesco Panza, Madia Lozupone, Vittorio Dibello, Antonio Greco, Antonio Daniele, Davide Seripa, Giancarlo Logroscino, Bruno P Imbimbo

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)3-6
Number of pages4
JournalImmunotherapy
Volume11
Issue number1
DOIs
Publication statusPublished - Jan 2019

Keywords

  • Alzheimer Disease/immunology
  • Amyloid Precursor Protein Secretases/antagonists & inhibitors
  • Amyloid beta-Peptides/immunology
  • Animals
  • Antibodies, Monoclonal, Humanized/therapeutic use
  • Aspartic Acid Endopeptidases/antagonists & inhibitors
  • Brain/metabolism
  • Clinical Trials as Topic
  • Humans
  • Immunotherapy/methods
  • Neuroprotective Agents/pharmacology
  • Peptides/immunology
  • Protein Multimerization

Cite this